360° SearchNetwork Hot Spots Trends Time Series

Advanced Search Options >>

Actonel

Type: Product

Name: Actonel

First reported May 20 2013 - Updated May 20 2013 - 1 reports

Actavis

Actavis (ACT) Paying $8.5B For Warner Chilcott (WCRX)

(By Balachander) Actavis Inc. (NYSE: ACT) has agreed to acquire women healthcare company Warner Chilcott Plc (NASDAQ: WCRX) for$ roughly$ $8.5 billion in stock or $20.08 per share.The deal represents a premium of 4.5 percent to Warner Chilcott's previous ... [Published I Stock Analyst - May 20 2013]

Entities: Actavis, Warner Chilcott plc, Osteoporosis, Synergism, Asacol

First reported May 20 2013 - Updated May 20 2013 - 1 reports

Actavis Acquiring Warner Chilcott for $8.5B

Actavis has agreed to acquire Warner Chilcott for about $8.5 billion, in a deal that expands the generic drug giant into the nation’s third-largest specialty pharmaceutical company with women's health, gastroenterology, urology, and dermatology among ... [Published Genetic Engineering News - May 20 2013]

Entities: Actavis, Warner Chilcott plc, Actonel, Gastroenterology, Dermatology

First reported May 17 2013 - Updated May 17 2013 - 1 reports

Irina Rivkind Comments: Ahead Of The Bell: Warner Chilcott

Shares of Warner Chilcott PLC rose before Monday's opening bell on optimism that it will eventually reach a deal to combine with fellow drugmaker Actavis Inc.The companies confirmed Friday that they're in early talks about a possible combination, but ... [Published Cantor Fitzgerald - May 17 2013]

Entities: Warner Chilcott plc, Actavis, Actonel, Drugs, Ulcerative Colitis

First reported May 16 2013 - Updated May 16 2013 - 1 reports

ACTONEL (Risedronate Sodium) Tablet, Film Coated [Warner Chilcott (US), LLC]

Updated Date: May 16, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - May 16 2013]

Entities: risedronate, Actonel, Warner Chilcott plc

First reported May 14 2013 - Updated May 14 2013 - 1 reports

Latest Updates About Warner Chilcott (WCRX)

Stockparlay.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets ... [Published SBWire - May 14 2013]

Entities: Warner Chilcott plc, Actavis, Actonel, Drugs, Ulcerative Colitis

First reported May 14 2013 - Updated May 14 2013 - 1 reports

Miu Miu

Miu Miu Tote Applying Skinny Jeans When.

This unique Ruby Calfskin Pocket book Front Medium Move may be anything you'd like think about since the colour is rich and trendy enough to prosper as a family trip bag. Aside from that, this will also make a large daily handcarry featuring its medium ... [Published Al Bawaba - May 14 2013]

Entities: Miu Miu, Olivia Munn, Gucci Group

First reported May 13 2013 - Updated May 13 2013 - 1 reports

Warner Chilcott plc

Earnings Beat at Warner Chilcott - Analyst Blog

Warner Chilcott’s (WCRX) first quarter 2013 earnings (excluding special items) of 92 cents per share handsomely beat the Zacks Consensus Estimate of 85 cents. Lower selling, general & administrative costs boosted earnings in the reported quarter.The company ... [Published Quote.com Australia - May 13 2013]

Entities: Warner Chilcott plc, Doryx, Actonel

First reported May 10 2013 - Updated May 10 2013 - 7 reports

Warner Chilcott PLC (WCRX) : Research and Markets

Equitymarketreport.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace ... [Published SBWire - May 10 2013]

Entities: Warner Chilcott plc, Asacol, Actonel, Net Earnings

First reported May 10 2013 - Updated May 10 2013 - 2 reports

Actavis and Warner Chilcott say they are in early discussions about a possible combination

, EDT. NEW YORK, N.Y. - The drugmakers Actavis Inc. and Warner Chilcott PLC say they are holding early discussions about a possible combination of the two companies.The companies say there is no guarantee that Actavis will make an offer for Warner Ch ... [Published 610 CKTB - May 10 2013]

Entities: Warner Chilcott plc, Actavis, Asacol, Actonel

First reported May 10 2013 - Updated May 10 2013 - 2 reports

Warner Chilcott Management Discusses Q1 2013 Results - Earnings Call Transcript

8:00 AM ETOperatorGood day, ladies and gentlemen, and welcome to the Warner Chilcott Announces First Quarter 2013 Financial Results Conference Call. [Operator Instructions] As a reminder, today's call is being recorded.I would now like to turn the conference ... [Published Seeking Alpha - May 10 2013]

Entities: Asacol, Doryx, Warner Chilcott plc, Asacol HD, Actonel

First reported May 09 2013 - Updated May 09 2013 - 1 reports

Can Warner Chilcott Start Growing Again?

The single, easiest way to keep track of all the stocks that matter...Your own personalized stock watchlist!It's a 100% FREE Motley Fool service... Warner Chilcott is a modestly sized pharmaceutical company specializing in products related to women's ... [Published Motley Fool - May 09 2013]

Entities: Warner Chilcott plc, watchlist, Actonel, Overactive Bladder

First reported May 03 2013 - Updated May 03 2013 - 1 reports

Life Sciences Update -- May 2013: Baker & McKenzie

ContactIncreased Regulation of Interactions with Healthcare ProfessionalsIn an effort to increase the transparency of interactions between pharmaceutical companies and health care professionals the new (17th) edition of the Medicines Australia Code of ... [Published JD Supra - May 03 2013]

Entities: Patent, Pharmaceutical Benefits Scheme, Crestor

Quotes

Citing the two companies' "complementary strengths," Bisaro said the deal "creates a strong specialty brand portfolio focused in therapeutic categories with strong growth potential, and is supported by a deep pipeline of development programs."

Actavis nabs Warner Chilcott in a $8.5B stock swap [Published FiercePharma - May 20 2013]

...in therapeutic categories with strong growth potential, and is supported by a deep pipeline of development programs," Bisaro said in the statement. "The combination is commercially and financially compelling, and reshapes the specialty pharmaceutical universe by creating a powerful global competitor. It creates a company with an exceptionally strong balance sheet, coupled with a favorable tax structure to support future growth."

Actavis Acquiring Warner Chilcott for $8.5B [Published Genetic Engineering News - May 20 2013]

Also, the deal won't create additional debt for Actavis, beyond the assumption of Warner-Chilcott's debt. That could put Actavis "in a position to quickly consider additional transactions post deal close" J P Morgan analyst Chris Schott said in a research note

2nd UPDATE: Actavis to Buy Warner Chilcott For $5 Billion in Stock [Published Nasdaq - May 20 2013]

"The fundamentals are not strong but that's why the stock is so cheap" Davis said

DEALTALK: Warner Chilcott buy may be Actavis' best takeover defense [Published Reuters - May 17 2013]

More Content

sort by: Date \| Relevance
Actavis to buy Warner Chilcott for $8.5 billion... [Published Drugtopics.com - May 21 2013]
Actavis, Inc., Warner Chilcott plc - M&A Call [Published Seeking Alpha - May 20 2013]
Actavis Uses Surging Stock to Snap Up Warner-Ch... [Published SBWire - May 20 2013]
Actavis nabs Warner Chilcott in a $8.5B stock swap [Published FiercePharma - May 20 2013]
Actavis Acquiring Warner Chilcott for $8.5B [Published Genetic Engineering News - May 20 2013]
Actavis buying Warner Chilcott in all-stock tra... [Published News 1130 - May 20 2013]
2nd UPDATE: Actavis to Buy Warner Chilcott For ... [Published Nasdaq - May 20 2013]
Actavis to Buy Warner Chilcott For $5 Billion i... [Published Nasdaq - May 20 2013]
Actavis to Buy Warner Chilcott For $5 Billion i... [Published Capital.gr - May 20 2013]
Actavis (ACT) Paying $8.5B For Warner Chilcott ... [Published I Stock Analyst - May 20 2013]
Keith Roach: Thyroid scores concern senior [Published Detroit News - May 20 2013]
Dear Dr. Roach: Elevated tsa does not always re... [Published Herald & Review - May 19 2013]
Irina Rivkind Comments: Ahead Of The Bell: Warn... [Published Cantor Fitzgerald - May 17 2013]
DEALTALK: Warner Chilcott buy may be Actavis' b... [Published Reuters - May 17 2013]
ACTONEL (Risedronate Sodium) Tablet, Film Coate... [Published DailyMed Drug Label Updates for the last seven ... - May 16 2013]
Latest Updates About Warner Chilcott (WCRX) [Published SBWire - May 14 2013]
Miu Miu Tote Applying Skinny Jeans When. [Published Al Bawaba - May 14 2013]
A Much Better Match for this Growing Pharma [Published Motley Fool - May 13 2013]
Radius Health CEO: Skin Patch Data is the Value... [Published Xconomy - May 13 2013]
Earnings Beat at Warner Chilcott - Analyst Blog [Published Quote.com Australia - May 13 2013]
Actavis in talks to buy Warner Chilcott [Published Pharma Times - May 11 2013]
Post Market News: Tesla Motors, Warner Chilcott... [Published Value Walk - May 11 2013]
Warner Chilcott PLC (WCRX) : Research and Markets [Published SBWire - May 10 2013]
Actavis and Warner Chilcott say they are in ear... [Published 610 CKTB - May 10 2013]
Actavis, Warner Chilcott discussing combination [Published Lowell Sun - May 10 2013]
Trader's Alert on Warner Chilcott [Published SBWire - May 10 2013]
Warner Chilcott 1Q net income holds steady [Published Equities.com - May 10 2013]
Warner Chilcott Management Discusses Q1 2013 Re... [Published Seeking Alpha - May 10 2013]
Warner Chilcott Q1 Profit Tops View, But Revenu... [Published RTTNews.com - May 10 2013]
Warner Chilcott Q1 Profit Flat; Backs FY13 Adj.... [Published FinanzNachrichten.de - May 10 2013]

Blogs

sort by: Date \| Relevance
ACTONEL (Risedronate Sodium) Tablet, Film Coate... [Published DailyMed Drug Label Updates for the last seven ... - May 16 2013] Updated Date: May 16, 2013 EST ...
Whistleblowers claim Warner execs flouted marke... [Published PharmaGossip - Mar 12 2013] via fiercepharma.com Two former Warner Chilcott reps have blown the whistle. In a False Claims Act lawsuit unsealed last week, the ex-salespeople detail a long series of allegations, including kickbacks, privacy violations and off-label shenanigans. ...
Sales Reps As Soccer Balls: Warner Chilcott & F... [Published Pharmalot - Mar 11 2013] In one of the more expansive whistleblower lawsuits to be filed against a drugmaker, a pair of former Warner-Chilcott sales reps have detailed numerous means in which they allege fraud was committed in order to boost sales of various prescription drugs. ...
Should Merck Have Known And Warned About Fosama... [Published Drug Injury Watch - Feb 09 2013] Intriguing New Medical/Chemical Journal Article Contends That Medicinal Chemists Or Pharmacologists At The Drug Company Could Have Anticipated Bisphosphonate-Related ONJ And Femur Fracture Cases (Posted by Tom Lamb at DrugInjuryWatch.com ) In ...
Atypical Femur Fractures: Due To Fosamax Or A B... [Published Drug Injury Watch - Jan 15 2013] The Fact That Fosamax Has Been Most Prescribed More Often Than Actonel, Aredia, Boniva, Etc., May Blur The Answer To This Drug-Safety Issue (Posted by Tom Lamb at DrugInjuryWatch.com ) In June 2012 the (then) Archives of Internal Medicine published ...

Press Releases

sort by: Date \| Relevance
For the Treatment of Osteoporosis, Patent Expir... [Published Business Wire Science: Science News - Dec 06 2012]
For the Treatment of Osteoporosis, Patent Expir... [Published EON Health & Medicine - Dec 06 2012]
For the Treatment of Osteoporosis, Patent Expir... [Published Business Wire Health News - Dec 06 2012]